CD8+ TIL Recruitment May Revert the Association of MAGE A3 with Aggressive Features in Thyroid Tumors

Figure 2

MAGE A3 expression in different lesions, (a) follicular adenoma (×200); (b) goiter (×200); (c) papillary thyroid carcinoma of the classic form (×200); (d) follicular variant of papillary thyroid carcinoma (×200), and (e) follicular carcinoma (×200).

(a)

(b)

(c)

(d)

(e)